.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Teva
Julphar
Cantor Fitzgerald
Mallinckrodt
Fuji
Cerilliant
Colorcon
Healthtrust

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040330

« Back to Dashboard
NDA 040330 describes PERCOCET, which is a drug marketed by Vintage Pharms Llc and is included in three NDAs. It is available from seven suppliers. Additional details are available on the PERCOCET profile page.

The generic ingredient in PERCOCET is acetaminophen; oxycodone hydrochloride. There are sixty-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

Summary for NDA: 040330

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 040330

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 040330

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERCOCET
acetaminophen; oxycodone hydrochloride
TABLET;ORAL 040330 ANDA Apotheca, Inc 12634-942 12634-942-40 40 TABLET in 1 BOTTLE (12634-942-40)
PERCOCET
acetaminophen; oxycodone hydrochloride
TABLET;ORAL 040330 ANDA Apotheca, Inc 12634-942 12634-942-60 60 TABLET in 1 BOTTLE (12634-942-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;2.5MG
Approval Date:Jun 25, 1999TE:AARLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;5MG
Approval Date:Jun 25, 1999TE:AARLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;7.5MG
Approval Date:Nov 23, 2001TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Citi
Medtronic
McKesson
Moodys
Novartis
Teva
AstraZeneca
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot